Surmodics (NASDAQ:SRDX) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Surmodics (NASDAQ:SRDX – Free Report) in a research note published on Thursday. The firm issued a buy rating on the stock. SRDX has been the subject of several other reports. Needham & Company LLC restated a buy rating and set a $50.00 target price (up from $36.00) on shares […]